Mesna
Mesna is a uroprotective medicine used to reduce the risk of haemorrhagic cystitis, a form of bladder inflammation and bleeding associated with chemotherapy medicines such as ifosfamide and, in selected regimens, cyclophosphamide. It works by binding to and neutralising the toxic metabolite acrolein in the urinary tract, protecting the bladder lining from damage. Mesna is commonly available as an intravenous injection and oral tablets or solution, depending on the market and treatment protocol. Possible side effects include nausea, vomiting, diarrhoea, headache, and injection-site reactions; hypersensitivity reactions may also occur. Adequate hydration and appropriate urine monitoring are important during treatment, and dosing must be coordinated with the chemotherapy schedule. Mesna should be administered under specialist supervision according to the prescribed oncology protocol.
Mesna was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Mesna, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Mesna from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Mesna, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
